FdaApplication
NDA 204325
Identifiers
- fda_app_no: NDA204325
Properties
| Property | Value |
|---|---|
| applicant_name | NEOS THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2017-09-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ADZENYS ER | AMPHETAMINE | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE;ORAL |
1 product